Clinical trials: Recurrent Ventricular Tachycardia
Ventricular Tachycardia
INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events
This study to is being conducted in India to determine the role of catheter-based ablation for ventricular tachycardia (VT) in post- heart attack patients who meet established guidelines for implantable cardiodefibrillator (ICD)…
- Trial name
- INTERVENE (NCT02301390)
- Testing
- Amiodarone, Catheter Ablation
- Where
- 3 sites in India
- Volunteers
- 53 people
- Sponsor
- Icahn School of Medicine at Mount Sinai
Ventricular Tachycardia
Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia
The purpose of the study is to assess the effectiveness and safety of a new device called an Intramural Needle Ablation Catheter (INA catheter).
- Trial name
- NCT01791543
- Testing
- Intramural Needle Ablation Catheter
- Where
- 2 sites in United States
- Volunteers
- 115 people
- Sponsor
- William Stevenson
Hyperkalemia
Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)
The purpose of this study is to evaluate the effect of Sodium Zirconium Cyclosilicate (SZC) on arrhythmia-related cardiovascular outcomes in participants on chronic hemodialysis with recurrent hyperkalemia.
- Trial name
- NCT04847232
- Testing
- Sodium Zirconium Cyclosilicate (SZC)
- Where
- 340 sites in United States, Argentina and 24 more
- Volunteers
- 2,690 people
- Sponsor
- AstraZeneca